18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging.

Radiolabeled cyclic arginine-glycine-aspartic (RGD) peptides can be used for noninvasive determination of integrin αvβ3 expression in tumors. In this study, we performed radiosynthesis and biological evaluation of a new 18F-labeled RGD homodimeric peptide with one 8-amino-3,6-dioxaoctanoic acid (PEG...

Full description

Bibliographic Details
Main Authors: Kongzhen Hu, Xiaolan Tang, Ganghua Tang, Shaobo Yao, Baoguo Yao, Hongliang Wang, Dahong Nie, Xiang Liang, Caihua Tang, Shanzhen He
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4580323?pdf=render
_version_ 1819066101318811648
author Kongzhen Hu
Xiaolan Tang
Ganghua Tang
Shaobo Yao
Baoguo Yao
Hongliang Wang
Dahong Nie
Xiang Liang
Caihua Tang
Shanzhen He
author_facet Kongzhen Hu
Xiaolan Tang
Ganghua Tang
Shaobo Yao
Baoguo Yao
Hongliang Wang
Dahong Nie
Xiang Liang
Caihua Tang
Shanzhen He
author_sort Kongzhen Hu
collection DOAJ
description Radiolabeled cyclic arginine-glycine-aspartic (RGD) peptides can be used for noninvasive determination of integrin αvβ3 expression in tumors. In this study, we performed radiosynthesis and biological evaluation of a new 18F-labeled RGD homodimeric peptide with one 8-amino-3,6-dioxaoctanoic acid (PEG2) linker on the glutamate β-amino group (18F-FP-PEG2-β-Glu-RGD2) as a symmetric PET tracer for tumor imaging. Biodistribution studies showed that radioactivity of 18F-FP-PEG2-β-Glu-RGD2 was rapidly cleared from blood by predominately renal excretion. MicroPET-CT imaging with 18F-FP-PEG2-β-Glu-RGD2 revealed high tumor contrast and low background in A549 human lung adenocarcinoma-bearing mouse models, PC-3 prostate cancer-bearing mouse models, and orthotopic transplanted C6 brain glioma models. 18F-FP-PEG2-β-Glu-RGD2 exhibited good stability in vitro and in vivo. The results suggest that this tracer is a potential PET tracer for tumor imaging.
first_indexed 2024-12-21T15:57:00Z
format Article
id doaj.art-5e2e448d258b4ec69ecdb3b49b24e7b9
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T15:57:00Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-5e2e448d258b4ec69ecdb3b49b24e7b92022-12-21T18:58:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01109e013867510.1371/journal.pone.013867518F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging.Kongzhen HuXiaolan TangGanghua TangShaobo YaoBaoguo YaoHongliang WangDahong NieXiang LiangCaihua TangShanzhen HeRadiolabeled cyclic arginine-glycine-aspartic (RGD) peptides can be used for noninvasive determination of integrin αvβ3 expression in tumors. In this study, we performed radiosynthesis and biological evaluation of a new 18F-labeled RGD homodimeric peptide with one 8-amino-3,6-dioxaoctanoic acid (PEG2) linker on the glutamate β-amino group (18F-FP-PEG2-β-Glu-RGD2) as a symmetric PET tracer for tumor imaging. Biodistribution studies showed that radioactivity of 18F-FP-PEG2-β-Glu-RGD2 was rapidly cleared from blood by predominately renal excretion. MicroPET-CT imaging with 18F-FP-PEG2-β-Glu-RGD2 revealed high tumor contrast and low background in A549 human lung adenocarcinoma-bearing mouse models, PC-3 prostate cancer-bearing mouse models, and orthotopic transplanted C6 brain glioma models. 18F-FP-PEG2-β-Glu-RGD2 exhibited good stability in vitro and in vivo. The results suggest that this tracer is a potential PET tracer for tumor imaging.http://europepmc.org/articles/PMC4580323?pdf=render
spellingShingle Kongzhen Hu
Xiaolan Tang
Ganghua Tang
Shaobo Yao
Baoguo Yao
Hongliang Wang
Dahong Nie
Xiang Liang
Caihua Tang
Shanzhen He
18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging.
PLoS ONE
title 18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging.
title_full 18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging.
title_fullStr 18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging.
title_full_unstemmed 18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging.
title_short 18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging.
title_sort 18f fp peg2 β glu rgd2 a symmetric integrin αvβ3 targeting radiotracer for tumor pet imaging
url http://europepmc.org/articles/PMC4580323?pdf=render
work_keys_str_mv AT kongzhenhu 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging
AT xiaolantang 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging
AT ganghuatang 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging
AT shaoboyao 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging
AT baoguoyao 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging
AT hongliangwang 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging
AT dahongnie 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging
AT xiangliang 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging
AT caihuatang 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging
AT shanzhenhe 18ffppeg2bglurgd2asymmetricintegrinavb3targetingradiotracerfortumorpetimaging